Tuesday Is Your Last Chance To Buy ResMed Before The Dividend Payout
Tuesday marks the last chance for investors to receive the next dividend payout from ResMed (NYSE:RMD).
RBC Capital Downgrades ResMed to Sector Perform, Raises Price Target to $252
RBC Capital analyst Craig Wong-Pan downgrades ResMed (NYSE:RMD) from Outperform to Sector Perform and raises the price target from $246 to $252.
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell
• Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
$100 Invested In This Stock 20 Years Ago Would Be Worth $3,400 Today
ResMed (NYSE:RMD) has outperformed the market over the past 20 years by 11.43% on an annualized basis producing an average annual return of 19.33%. Currently, ResMed has a market capitalization of $35.01 billion.
How Is The Market Feeling About ResMed?
ResMed's (NYSE:RMD) short percent of float has fallen 6.8% since its last report. The company recently reported that it has 1.39 million shares sold short, which is 0.96% of all regular shares that are available for trading.
Semiconductor Shortages – See How ResMed Is Tackling
ResMed Inc (NYSE: RMD) has redesigned the AirSense 10 to eliminate a short-supply semiconductor chipset used for cellular communications chips.
Here’s How Much $1000 Invested In ResMed 10 Years Ago Would Be Worth Today
ResMed (NYSE:RMD) has outperformed the market over the past 10 years by 10.69% on an annualized basis producing an average annual return of 21.91%. Currently, ResMed has a market capitalization of $32.57 billion.
Here’s How Much You Would Have Made Owning ResMed Stock In The Last 20 Years
ResMed (NYSE:RMD) has outperformed the market over the past 20 years by 11.66% on an annualized basis producing an average annual return of 18.75%. Currently, ResMed has a market capitalization of $30.88 billion.